Int J Immunopharmacol. 1992 Apr;14(3):505-10.

The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.

Bell RL, Young PR, Albert D, Lanni C, Summers JB, Brooks DW, Rubin P, Carter GW.

Source

Immunoscience Research Area and Immunoscience Venture, Abbott Laboratories, Abbott Park, IL 60064.

Abstract

The enzyme 5-lipoxygenase is a key target in the effort to discover drugs which inhibit the pathophysiology associated with the formation of leukotrienes. The research efforts of these laboratories have focused on the discovery of direct enzyme inhibitors of 5-lipoxygenase. In particular, compounds with hydroxamate or N-hydroxyurea functionalities have proven to be potent inhibitors of leukotriene biosynthesis in vitro and more importantly in vivo. One of these compounds, zileuton (N-(1-benzo-[b]-thien-2-ylethyl)-N-hydroxyurea) has been shown recently to be an effective leukotriene inhibitor in man. The critical approaches and breakthroughs in the discovery and development of zileuton are described. In addition, some recent results with zileuton in animals and man are detailed.

PMID:: 1618602; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Supplemental Content

Save items

Related citations in PubMed

Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase. [Agents Actions Suppl. 1991]
Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.
Rubin P, Dubé L, Braeckman R, Swanson L, Hansen R, Albert D, Carter G. Agents Actions Suppl. 1991; 35:103-16.
Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. [J Allergy Clin Immunol. 1996]
Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
Liu MC, Dubé LM, Lancaster J. J Allergy Clin Immunol. 1996 Nov; 98(5 Pt 1):859-71.
The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis. [Pulm Pharmacol. 1994]
The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis.
Malo PE, Bell RL, Shaughnessy TK, Summers JB, Brooks DW, Carter GW. Pulm Pharmacol. 1994 Apr; 7(2):73-9.
Review Designing therapeutically effective 5-lipoxygenase inhibitors. [Trends Pharmacol Sci. 1992]
Review Designing therapeutically effective 5-lipoxygenase inhibitors.
McMillan RM, Walker ER. Trends Pharmacol Sci. 1992 Aug; 13(8):323-30.
Review [The role of leukotrienes in inflammation and leukotriene inhibitors]. [Pol Merkur Lekarski. 1999]
Review [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M, Kuna P. Pol Merkur Lekarski. 1999 Sep; 7(39):85-93.

See reviews... See all...

Cited by 3 PubMed Central articles

The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. [Br J Pharmacol. 2010]
The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages.
Rossi A, Pergola C, Koeberle A, Hoffmann M, Dehm F, Bramanti P, Cuzzocrea S, Werz O, Sautebin L. Br J Pharmacol. 2010 Oct; 161(3):555-70.
A macrophage cell model for selective metalloproteinase inhibitor design. [Chembiochem. 2008]
A macrophage cell model for selective metalloproteinase inhibitor design.
Jacobsen FE, Buczynski MW, Dennis EA, Cohen SM. Chembiochem. 2008 Sep 1; 9(13):2087-95.
Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity. [Proc Natl Acad Sci U S A. 1994]
Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity.
Guidot DM, Repine MJ, Westcott JY, Repine JE. Proc Natl Acad Sci U S A. 1994 Aug 16; 91(17):8156-9.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The discovery and development of zileuton: an orally active 5-lipoxygenase inhib...
The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
Int J Immunopharmacol. 1992 Apr ;14(3):505-10.

PubMed
Functional neuroimaging during altered states of consciousness: how and what do ...
Functional neuroimaging during altered states of consciousness: how and what do we measure?
Prog Brain Res. 2005 ;150:25-43.

PubMed
IL-6 receptor and mechanism of signal transduction.
IL-6 receptor and mechanism of signal transduction.
Int J Immunopharmacol. 1992 Apr ;14(3):431-8.

PubMed
Characterization of articular cartilage and subchondral bone changes in the rat ...
Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis.
Bone. 2006 Feb ;38(2):234-43. Epub 2005 Sep 26 .

PubMed
Return to work of road accident victims claiming compensation for personal injur...
Return to work of road accident victims claiming compensation for personal injury.
Injury. 1992 ;23(4):256-60.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information